EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Ferroptosis‐Mediated Placental Dysfunction in the Pathophysiology of Gestational Diabetes Mellitus

S Monisha, K L Milan, M Anuradha, K M Ramkumar

American Journal of Reproductive Immunology · 2026-07 · 96 (1)

DOI: 10.1111/aji.70288 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Problem Gestational diabetes mellitus (GDM) is a common metabolic complication of pregnancy associated with adverse maternal and fetal outcomes. Nevertheless, the molecular mechanism of placental dysfunction in GDM are still not clear, especially the role of ferroptosis and its interplay with oxidative stress, inflammation, and angiogenesis. Method of Study Placental tissues from GDM pregnancies were examined to assess oxidative stress, antioxidant defense, ferroptosis regulation, inflammatory signaling, and angiogenic pathways. Expression levels of key molecular markers were evaluated, and correlation analyses were performed to identify mechanistic interrelationships. Results GDM placenta demonstrated elevated oxidative stress markers, including P22PHOX and TXNIP, accompanied by reduced antioxidant markers, such as HO‐1, NQO1, SOD2, and CAT, indicating impaired cellular defense. Ferroptosis regulation was disrupted, as anti‐ferroptotic markers GPX4, SLC7A11, and NRF2 were significantly downregulated, while pro‐ferroptotic markers TFR1 and ACSL4 were increased, suggesting enhanced iron accumulation and lipid peroxidation. This was accompanied by heightened inflammation, evidenced by increased IL‐6, IL‐1β, TNF‐α, and NF‐κB activation, alongside reduced IL‐10 expression. Furthermore, angiogenesis was impaired, reflected by decreased VEGFA, HIF‐1α, and SDF‐1α levels, highlighting poor vascular development in the placenta. Additionally, Correlation analyses demonstrated strong associations between ferroptosis markers and oxidative stress, inflammatory, and angiogenic pathways, suggesting the possible presence of an interconnected regulatory network. Conclusions These findings identify ferroptosis as a central regulator of GDM‐associated placental dysfunction, through a possible interconnected network of oxidative stress, inflammation, and impaired angiogenesis. Targeting ferroptosis may offer a possible therapeutic option to restore placental function and improve maternal‐fetal outcomes in GDM.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →